| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 37.216 | 0 | 1.074 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 37.237 | 18 | 1.082 | 0 | 3 | 1 | 1 | 0 | 0 |
| Total Expenses - EUR | - | 7.526 | 1.292 | 810 | 488 | 494 | 546 | 377 | 12 | 0 |
| Gross Profit/Loss - EUR | - | 29.711 | -1.274 | 272 | -488 | -491 | -545 | -376 | -12 | 0 |
| Net Profit/Loss - EUR | - | 28.594 | -1.274 | 240 | -488 | -491 | -545 | -376 | -12 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Topepa Med Npa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 29.849 | 7.315 | 2.269 | 1.681 | 1.158 | 587 | 92 | 80 | 80 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 29.849 | 7.315 | 2.269 | 1.681 | 1.158 | 587 | 92 | 80 | 80 |
| Shareholders Funds | - | 28.638 | 7.293 | 2.083 | 1.554 | 1.034 | 466 | 92 | 80 | 80 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.210 | 22 | 187 | 126 | 124 | 121 | 0 | 0 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8230 - 8230" | |||||||||
| CAEN Financial Year |
8230
|
|||||||||
Comments - Topepa Med Npa Srl